scholarly journals Latency of α-Herpes Viruses Is Accompanied by a Chronic Inflammation in Human Trigeminal Ganglia But Not in Dorsal Root Ganglia

2006 ◽  
Vol 65 (10) ◽  
pp. 1022-1030 ◽  
Author(s):  
Katharina Hüfner ◽  
Tobias Derfuss ◽  
Simone Herberger ◽  
Kishiko Sunami ◽  
Steven Russell ◽  
...  
2011 ◽  
Vol 71 ◽  
pp. e95
Author(s):  
Ze-lan Hu ◽  
Ming Shi ◽  
Ying Huang ◽  
Min-Hua Zheng ◽  
Zhe Pei ◽  
...  

genesis ◽  
2004 ◽  
Vol 38 (3) ◽  
pp. 122-129 ◽  
Author(s):  
Nitin Agarwal ◽  
Stefan Offermanns ◽  
Rohini Kuner

2014 ◽  
Vol 146 (5) ◽  
pp. S-824-S-825
Author(s):  
Raquel Guerrero-Alba ◽  
Eduardo E. Valdez-Morales ◽  
Alan Lomax ◽  
Stephen J. Vanner

1997 ◽  
Vol 15 (6) ◽  
pp. 717-727 ◽  
Author(s):  
P.D. Kitchener ◽  
K.M. Dziegielewska ◽  
G.W. Knott ◽  
J.M. Miller ◽  
P. Nawratil ◽  
...  

2017 ◽  
Vol 69 (1) ◽  
pp. 53-59 ◽  
Author(s):  
Antonia-Teona Deftu ◽  
Alexandru-Florian Deftu ◽  
Violeta Ristoiu

CXCL1 and CXCL2 are homologous chemokines that can be upregulated in different pathological conditions, affecting among other targets, neuronal ionic channels or receptors. TRPV1 is a polymodal nociceptor expressed in both dorsal root and trigeminal ganglia neurons. According to existing data, short-term incubation with CXCL1 can reduce TRPV1 desensitization, however, the long-term modulatory effect of both CXCL1 and CXCL2 on this receptor is less known. In the present study we investigated the influence of overnight incubation with 1.5 nM CXCL1 or CXCL2 on the functioning of TRPV1 receptors expressed in cultured dorsal root ganglia neurons. Calcium imaging and patch-clamp recordings showed that under the same experimental conditions and at the same concentration, only CXCL2 significantly decreased the TRPV1 current and increased its desensitization rate, whereas CXCL1 had no effect. This study proposes a different contribution of CXCL1 and CXCL2 to the modulation of TRPV1-mediated processes, in spite of their highly homologous sequence.


2008 ◽  
Vol 596 (1-3) ◽  
pp. 62-69 ◽  
Author(s):  
Heath A. McDonald ◽  
Torben R. Neelands ◽  
Michael Kort ◽  
Ping Han ◽  
Melissa H. Vos ◽  
...  

Neuroscience ◽  
2017 ◽  
Vol 350 ◽  
pp. 169-179 ◽  
Author(s):  
Lisette Johanna Antonia Kogelman ◽  
Rikke Elgaard Christensen ◽  
Sara Hougaard Pedersen ◽  
Marcelo Bertalan ◽  
Thomas Folkmann Hansen ◽  
...  

Author(s):  
V.J. Montpetit ◽  
S. Dancea ◽  
L. Tryphonas ◽  
D.F. Clapin

Very large doses of pyridoxine (vitamin B6) are neurotoxic in humans, selectively affecting the peripheral sensory nerves. We have undertaken a study of the morphological and biochemical aspects of pyridoxine neurotoxicity in an animal model system. Early morphological changes in dorsal root ganglia (DRG) associated with pyridoxine megadoses include proliferation of neurofilaments, ribosomes, rough endoplasmic reticulum, and Golgi complexes. We present in this report evidence of the formation of unique aggregates of microtubules and membranes in the proximal processes of DRG which are induced by high levels of pyridoxine.


2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 55.2-56
Author(s):  
R. Raoof ◽  
C. Martin ◽  
H. De Visser ◽  
J. Prado ◽  
S. Versteeg ◽  
...  

Background:Pain is a major debilitating symptom of knee osteoarthritis (OA). However, the extent of joint damage in OA does not correlate well with the severity of pain. The mechanisms that govern OA pain are poorly understood. Immune cells infiltrating nervous tissue may contribute to pain maintenance.Objectives:Here we investigated the role of macrophages in the initiation and maintenance of OA pain.Methods:Knee joint damage was induced by an unilateral injection of mono-iodoacetate (MIA) or after application of a groove at the femoral condyles of rats fed on high fat diet. Pain-like behaviors were followed over time using von Frey test and dynamic weight bearing. Joint damage was assessed by histology. Dorsal root ganglia (DRG) infiltrating immune cells were assessed over time using flow cytometry. To deplete monocytes and macrophages, Lysmcrex Csfr1-Stop-DTR were injected intrathecal or systemically with diptheria toxin (DT).Results:Intraarticular monoiodoacetate injection induced OA and signs of persistent pain, such as mechanical hyperalgesia and deficits in weight bearing. The persisting pain-like behaviors were associated with accumulation of F4/80+macrophages with an M1-like phenotype in the lumbar DRG appearing from 1 week after MIA injection, and that persisted till at least 4 weeks after MIA injection. Macrophages infiltrated DRG were also observed in the rat groove model of OA, 12 weeks after application of a groove at the femoral condyles. Systemic or local depletion of DRG macrophages during established MIA-induced OA completely ablated signs of pain, without affecting MIA-induced knee pathology. Intriguingly when monocytes/macrophages were depleted prior to induction of osteoarthritis, pain-like behaviors still developed, however these pain-like behaviors did not persist over time.In vitro,sensory neurons innervating the affected OA joint programmed macrophages into a M1 phenotype. Local repolarization of M1-like DRG macrophages towards M2 by intrathecal injection of M2 macrophages or anti-inflammatory cytokines resolved persistent OA-induced pain.Conclusion:Overall we show that macrophages infiltrate the DRG after knee damage and acquire a M1-like phenotype and maintain pain independent of the lesions in the knee joint. DRG-infiltrating macrophages are not required for induction of OA pain. Reprogramming M1-like DRG-infiltrating macrophages may represent a potential strategy to treat OA pain.Acknowledgments:This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreements No 814244 and No 642720. Dutch Arthritis SocietyDisclosure of Interests:Ramin Raoof: None declared, Christian Martin: None declared, Huub de Visser: None declared, Judith Prado: None declared, Sabine Versteeg: None declared, Anne Heinemans: None declared, Simon Mastbergen: None declared, Floris Lafeber Shareholder of: Co-founder and shareholder of ArthroSave BV, Niels Eijkelkamp: None declared


Sign in / Sign up

Export Citation Format

Share Document